Has Gauri Mankekar, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,603 in general payments to Gauri Mankekar, MD across 72 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Gauri Mankekar, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Gauri Mankekar, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Gauri Mankekar, MD

Otology & Neurotology · Shreveport, LANPI 1881114916

Payments from drug & device makers

$4,603in general payments, 2019–2025

Across 72 payments — averaging $63.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Cochlear Americas$2K
Med-el Corporation$1K
Medtronic$676
Boehringer Ingelheim$255
Olympus America Inc.$255
Carl Zeiss Meditec USA, Inc.$148
plus $476 from 11 others

What the payments were for

Speaking & faculty fees$1483%
Travel & lodging$2,39852%
Food & beverage$2,05745%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Cochlear Americas	15	$1,711
Med-el Corporation	5	$1,083
Medtronic(2 entities)	12	$676
Boehringer Ingelheim	14	$255
Olympus America Inc.	8	$255
Carl Zeiss Meditec USA, Inc.	1	$148
Grace Medical, Inc.	1	$100
Intersect ENT, Inc.	2	$77
Stryker	1	$55
AstraZeneca	3	$47
Aerin Medical Inc.	2	$42
Inspire Medical Systems, Inc.	1	$37
Advanced Bionics, LLC	2	$36
Teva Pharmaceuticals USA, Inc.	2	$29
Tempus AI, Inc	1	$21
Takeda Pharmaceuticals U.S.A., Inc.	1	$19
Covidien LP	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otology & neurotology providers in Louisianato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$55,611

Medicare patients

276

Services billed

510

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ofloxacin	39	$987
Fluticasone Propionate	27	$394

Paid to pharmacies, not to this prescriber.

Other otology & neurotology in Shreveport

Lawrence GardnerShreveport$472
Neal JacksonNew Orleans$8K
Adam MasterNew Orleans$6K
Moises ArriagaBaton Rouge$3K
Gerard GianoliBaton Rouge$659

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →